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1918 virus, and the resultant data
further support the conclusions made
by McAuley et al. that the PB1-F2 of
1918 virus contributes to the extreme
virulence of the virus inmice. However,
none of the recent work on PB1-F2
and more specifically on the PB1-F2
of the 1918 pandemic virus provides
a molecular mechanism for the ability
of the 1918 PB1-F2 to cause macro-
phage and neutrophil infiltration into
the lung or increase morbidity. Fur-
thermore, there have been no studies
connecting the known apoptotic func-
tion of PB1-F2 in vitro to the increased
in vivo pathogenesis, or to the ability
of PB1-F2 to bind PB1 (S. Ludwig,
personal communication).
It seems the more we know about
PB1-F2, the more puzzling questions
there are to ponder. Howcouldwepre-
vent thedetrimental effects ofPB1-F2?
Would it be possible to inhibit the activ-
ity of PB1-F2 through smart design
of small-molecule drugs? What role
does cytokine dysregulation have in in-
creasing lung pathology, and can we
prevent it by abrogating the function
of PB1-F2? Exactly how is the C-termi-
nal PB1-F2 peptide getting into cells
to impact cell recruitment, or alterna-
tively, isC-terminal PB1-F2evenenter-
ing cells at all? Lastly, could this pep-
tide or full-length PB1-F2 be found
extracellularly in a natural infection?
Truly exciting work is now being done
with PB1-F2, but there are still many
holes in the knowledge we have about
influenza’s smallest protein.
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ChronicHelicobacter pylori infection is the strongest known risk factor for the development of gastric
cancer. In order to survive and propagate under the harsh conditions of the gastric niche, this path-
ogen has evolved numerous means to interact with host epithelium. In this issue, Mimuro et al. shed
light on mechanisms by which Helicobacter pylori attenuates apoptosis in the gastric epithelium to
facilitate its persistence within the human stomach.Helicobacter pylori (H. pylori) has in-
fected human stomachs for more
than 55,000 years, with colonization
typically lasting for the lifetime of its
host (Linz et al., 2007). This bacterium
colonizes more than 50% of the
world’s population, thereby establish-
ing itself as one of the most successful
human pathogens. H. pylori has devel-
oped numerous strategies to colonize
and thrive within the hostile environ-ment of the stomach. These include
evasion of the host immune response,
gaining access to nutrients, protection
against the inherent acidic environ-
ment, adherence to the gastric epithe-
lium, and resisting peristalsis and rapid
cellular turnover. Several lines of evi-
dence have also indicated that, within
gastric mucosa, H. pylori is able to
modify signaling events that couple
epithelial andmesenchymal cells in or-Cell Host & Microbeder to tailor an environment optimal for
its own survival. However, although all
colonized individuals develop chronic
gastritis, only a mere subset will de-
velop gastric adenocarcinoma (Peek
and Crabtree, 2006). H. pylori viru-
lence constituents clearly modify dis-
ease risk, and strains that possess
the cag island, a type IV secretion sys-
tem that functions to translocate its
substrate CagA into host cells, further2, October 2007 ª2007 Elsevier Inc. 209
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PreviewsFigure 1. Translocation of CagA by H. pylori into Gastric Epithelial Cells Disrupts
the Balance between Apoptosis and Proliferation
Translocation of CagA into gastric epithelial cells increases expression of MCL1 in pit cells via
a mechanism involving MEK/ERK activation and SRE/SRF transcription, resulting in a prosurvival
phenotype. H. pylori may also contribute to increased pit cell number by increasing MMP-7 pro-
duction by epithelial cells. MMP-7 subsequently cleaves the binding protein IGFBP-5, resulting
in biologically active IGF-II and increased proliferation of epithelial and subepithelial cells.augment the risk for gastric cancer
(Blaser et al., 1995).
The gastric epithelium consists of
a single layer of cells that invaginates
to form highly organized tubular struc-
tures (gastric glands), which contain
a distinct variety of cell types. The re-
gion in closest proximity to the gastric
lumen is termed the pit and is primarily
composed of surface mucous cells.
The region adjacent to the pit is the
isthmus, which contains stem cells
that spawn differentiated cell lineages.
The isthmus is bordered by the neck
region containing mucous neck cells,
and the base of the gland, which con-
sists primarily of chief cells. Parietal
cells and endocrine cells are scattered
throughout the gland (Karam and Leb-
lond, 1995). Gastric epithelial cells un-
dergo constant turnover, the rate of
which increases following damage to
the epithelium. As such, it is imperative
that a tightly regulated balance is
maintained between apoptosis, prolif-
eration, and differentiation to prevent
normal healing from transitioning into
disease states. From the standpoint
of a chronic microbial pathogen, the
efficiency of colonization is increased
if cell survival is supported. Mimuro
and colleagues now report that H.
pylori can attenuate gastric epithelial210 Cell Host & Microbe 2, October 2007cell apoptosis and sustain cell survival
in a CagA-dependent manner and that
these events increase bacterial coloni-
zation (Mimuro et al., 2007).
In this study, the chemotherapeutic
agent Etoposide was used to induce
gastric pit cell apoptosis in the stom-
achs of Mongolian gerbils, a robust ro-
dent model of H. pylori-induced injury.
H. pylori infection alone for 8weeks did
not significantly affect levels of apo-
ptosis. However, precolonization with
H. pylori prior to Etoposide administra-
tion protected gastric pit cells from ap-
optosis. Moreover, infection with an
isogenic cagA mutant H. pylori strain
revealed that CagA was required for
this antiapoptotic response. Utilizing
Mongolian gerbil and in vitro gastric
epithelial cell models, the authors fur-
ther demonstrated that CagA translo-
cation into gastric epithelial cells acti-
vated the MEK/ERK pathway and
increased Serum Response Element
(SRE)/Serum Response Factor (SRF)-
driven gene transcription, which
promoted cell survival (Figure 1). The
antiapoptotic protein Myeloid cell leu-
kemia sequence-1 (MCL1) is a SRE/
SRF target that is tightly regulated
by growth and differentiation factors
and functions to promote cell survival
(Craig, 2002). Consistent with theirª2007 Elsevier Inc.previous results, Mimuro et al. found
that MCL1 levels were also regulated
in a CagA-dependent manner via a
pathway that involved activation of
MEK/ERK and SRE/SRF transcription.
Of interest, increased expression of
MCL1 localized predominantly to the
pit region.H. pylori infection in humans
leads to increased proliferation rates
with extension of the proliferative zone
from the isthmus toward the pit region
ofgastricglands.The resultsgenerated
by Mimuro et al. now suggest that
hyperplasia observed in response to
H. pylori infection is not only due to in-
creased cellular proliferation, but may
also be due to antiapoptotic responses
exerted by H. pylori CagA-positive
strains.
Dynamic and intimate interactions
occur between gastric epithelial and
subepithelial cells (including fibroblasts
and myofibroblasts), and such inter-
actions are crucial for maintaining mu-
cosal organization. Endocrine and
paracrine mediators regulate gastric
epithelial architecture, but recently it
has beendemonstrated that proteolytic
enzymes are also important (McCaig
et al., 2006; Varro et al., 2007). Matrix
metalloproteinases (MMPs) are capa-
ble of degrading all components of
the extracellular matrix (ECM), are in-
volved in the physiological turnover of
ECM, and have a crucial role in patho-
physiological processes, such as tumor
invasion and metastasis (Nagase and
Woessner, 1999). MMPs are typically
produced by subepithelial cells; how-
ever, MMP-7 is predominantly ex-
pressed by epithelial cells. Recent evi-
dence indicates that H. pylori exploits
MMP-7 to aberrantly regulate interac-
tions between epithelial and subepithe-
lial cells (McCaig et al., 2006). H. pylori
increases MMP-7 expression in gastric
epithelial cells (Crawford et al., 2003;
Wroblewski et al., 2003), and elegant
work by McCaig et al. has demon-
strated that these elevated levels of
MMP-7 cleave insulin-like growth fac-
tor-binding protein (IGFBP)-5 secreted
from myofibroblasts, leading to in-
creased extracellular concentrations of
insulin-like growth factor (IGF)-II, which
subsequently increases gastric epithe-
lial cell proliferation in a positive feed-
back system (Figure 1). Since MMP-7
can also exert antiapoptotic effects
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tant to determine whether epithelial-
mesenchymal signaling is involved in
the survival phenotype reported by
Mimuro et al. and others.
The present study by Mimuro and
colleagues has enhanced our under-
standing of the complex and active in-
terplay that occurs between H. pylori
and epithelial cells. However, it is clear
that there are stillmanyviablequestions
regarding the biology of H. pylori and
mechanisms by which this bacterium
is able to manipulate the highly regu-
lated organization of the gastric epithe-
lium, which over time can promote the
progression from normal gastric mu-
cosa to gastric adenocarcinoma.Symbiont Genes
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While lateral transfer is the rule
of transfer from prokaryotes to e
asWolbachia pipientis, are well p
Dunning Hotopp et al. identified
unknown whether these transfer
Lateral gene transfer (LGT; also known
as horizontal gene transfer) is a major
feature of bacterial and archaeal ge-
nome evolution. Through this mecha-
nism, lineages can acquire important
functions wholesale from other line-
ages, and thus improve their relative
fitness. While LGT has an ancient his-
tory in prokaryotes, it is an ongoing
process, as evidenced by the emer-
gence of drug-resistant pathogens in
human communities. In contrast, lat-
eral gene transfer in eukaryotes ap-
pears to be rare. For animals, the early
segregation of germline cells in devel-
opment is likely to make LGT eventsREFERENCES
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in the evolutionary history of bacte
ukaryotes are rare. Germline-tran
laced to participate in such transf
instances of transfer of Wolbac
s represent innovation in animal ev
rarer than in eukaryotes without a seg-
regated germline. One textbook exam-
ple, the acquisition of cellulase genes
by termites from a bacterial source,
has recently been shown to be errone-
ous (Davison and Blaxter, 2005), and
initial excitement about ‘‘bugs in our
genome’’ from the initial analysis of the
human genome (Lander et al., 2001)
has evaporated, as these genes have
been shown to be present in other
eukaryotes and thus more probably
part of the core eukaryote genome
(Salzberg et al., 2001). Is LGT a signifi-
cant, ongoing process in animal
genomes?
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olution.
Animals can be infected with germ-
line-transmitted symbionts, and these
bacterial genomes are thus in just
the right position to be donors in LGT
events. There are several groups of an-
imal germline symbionts, and the best
studied are the a-proteobacterialWol-
bachia parasites of arthropods and
nematodes. First discovered in mos-
quitoes, Wolbachia pipientis induces
a range of reproductive manipulation
phenotypes in infected hosts (such as
mating type incompatibility, feminiza-
tion of genetic males, and induction
of parthenogenesis) that increase the
relative fitness of the host, and thus
2, October 2007 ª2007 Elsevier Inc. 211
